Emerging News 

Looks Attractive Again:: Amgen Inc., (NASDAQ: AMGN)

On Tuesday, February 04, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $221.81 in the latest trading session, marking a 2.27% move from the prior day. The overall total volume in the last trading session was 2582892 shares while it’s while its relative trading volume is 1.13. The price target set for the stock is $245.5. The beta factor is 1.1. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

This Will Sum Up The Whole Scenario:: Amgen Inc., (NASDAQ: AMGN)

On Monday, February 03, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $216.88 in the latest trading session, marking a 0.38% move from the prior day. The overall total volume in the last trading session was 2434524 shares while it’s while its relative trading volume is 1.06. The price target set for the stock is $245.5. The beta factor is 1.1. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

Happy To Be Back In The Pack:: Amgen Inc., (NASDAQ: AMGN)

On Friday, January 31, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $216.05 in the latest trading session, marking a -4.47% move from the prior day. The overall total volume in the last trading session was 5955870 shares while it’s while its relative trading volume is 2.65. The price target set for the stock is $237. The beta factor is 1.11. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

This Will Sum Up The Whole Scenario:: Amgen Inc., (NASDAQ: AMGN)

On Thursday, January 30, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $226.15 in the latest trading session, marking a -0.44% move from the prior day. The overall total volume in the last trading session was 2516962 shares while it’s while its relative trading volume is 1.11. The price target set for the stock is $237. The beta factor is 1.11. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

Happy To Be Back In The Pack:: Amgen Inc., (NASDAQ: AMGN)

On Monday, January 27, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $222.95 in the latest trading session, marking a -1.17% move from the prior day. The overall total volume in the last trading session was 2720087 shares while it’s while its relative trading volume is 1.19. The price target set for the stock is $237. The beta factor is 1.11. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

Is Technical Outlook Good?: Amgen Inc., (NASDAQ: AMGN)

On Friday, January 24, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $225.59 in the latest trading session, marking a -4.02% move from the prior day. The overall total volume in the last trading session was 5009120 shares while it’s while its relative trading volume is 2.26. The price target set for the stock is $237. The beta factor is 1.11. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More
Emerging News 

A Great Combo Of Value And Growth?: Amgen Inc., (NASDAQ: AMGN)

On Tuesday, January 21, 2020, Amgen Inc., (NASDAQ: AMGN) closed at $237.6 in the latest trading session, marking a -1.61% move from the prior day. The overall total volume in the last trading session was 3071079 shares while it’s while its relative trading volume is 1.4. The price target set for the stock is $237. The beta factor is 1.11. A stock with a beta more than 1 means high volatile and less than 1 means low volatile. The RSI index is largely used by traders on a 14.0-day time…

Read More

Complete growth overview on Psoriatic Arthritis Market in 2020-2026 including top key players Celgene Corporation, Amgen Inc, AbbVie, etc.

Psoriatic Arthritis Market Analysis: Psoriatic Arthritis Market has exhibited continuous growth in recent years and is projected to grow even further during the forecast period (2020-2026). The research documents a detailed analysis of the market, compiling Current Growth Factors, Future trends, attentive opinions, historical data, facts and statistically supported and industry-validated market data. The Psoriatic Arthritis research report also provides an overall analysis of the market share, size, segmentation, revenue forecasts and geographic regions of the Psoriatic Arthritis in addition to an in-depth study of industry-leading players, with respect to…

Read More